Ronit Satchi-Fainaro is first place winner in competition for Entrepreneurial Translational Research

Ronit is a Professor at the Faculty of Medicine and director of the Cancer Biology Research Center at Tel Aviv University, and a co-founder and chief scientific officer (CSO) of Israel-based TanoMed. Their technology trains host immunity in the tumor microenvironment against a specific member of the carcinoembryonic antigen-related cell adhesion molecule family, CEACAM5, that plays a prominent role in gastrointestinal cancers.

For more information:

https://www.nfcr.org/blog/national-foundation-for-cancer-research-announces-2021-salisbury-award-competition-winners-2021/#:~:text=The%20first%20prize%20winner%20of,its%20Cancer%20Biology%20Research%20Center